An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

Part of paid clinical trials in Newport Beach, California.

Sponsor
Vanda Pharmaceuticals
Study ID
NCT07179055
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • VSJ-110 — DRUG
    ophthalmic solution
  • Placebo — DRUG
    ophthalmic solution

Study Details

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Key Dates

Start date
Oct 31, 2025
Status verified
Sep 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
160 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: VSJ-110 Solution
  • Placebo Comparator: Placebo Solution

Primary Outcome Measure

Corneal Staining [ Time Frame: Measured over an 8-week treatment period ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Vanda Investigational SiteNewport BeachCalifornia92663
Vanda Pharmaceuticals
202-734-3400
Vanda Investigational SiteAndoverMassachusetts01810
Vanda Pharmaceuticals
202-734-3400
Vanda Investigational SiteShelbyNorth Carolina28150
Vanda Pharmaceuticals
202-734-3400
Vanda Investigational SiteMemphisTennessee38119
Vanda Pharmaceuticals
202-734-3400
Vanda Investigational SiteLynchburgVirginia24502
Vanda Pharmaceuticals
202-734-3400

Find similar trials in Newport Beach, CA

By research site
Vanda Investigational Site· Newport Beach, CAVanda Investigational Site· Andover, MAVanda Investigational Site· Shelby, NCVanda Investigational Site· Memphis, TNVanda Investigational Site· Lynchburg, VA

Related Studies